CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation.

Saved in:
Bibliographic Details
Title: CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation.
Authors: Rasool RU; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Natesan R; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Deng Q; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Aras S; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Lal P; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Sander Effron S; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Mitchell-Velasquez E; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Posimo JM; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Carskadon S; Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan., Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Siddiqui J; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan., Schwartz LE; Department of Pathology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Lee DJ; Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Palanisamy N; Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan., Narla G; Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Den RB; Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Brady DC; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Asangani IA; Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. asangani@upenn.edu.; Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Source: Cancer discovery [Cancer Discov] 2019 Nov; Vol. 9 (11), pp. 1538-1555. Date of Electronic Publication: 2019 Aug 29.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-19-0189